ATE445011T1 - Hemopoietin-rezeptor und dafür kodierende genetische sequenzen - Google Patents

Hemopoietin-rezeptor und dafür kodierende genetische sequenzen

Info

Publication number
ATE445011T1
ATE445011T1 AT96934193T AT96934193T ATE445011T1 AT E445011 T1 ATE445011 T1 AT E445011T1 AT 96934193 T AT96934193 T AT 96934193T AT 96934193 T AT96934193 T AT 96934193T AT E445011 T1 ATE445011 T1 AT E445011T1
Authority
AT
Austria
Prior art keywords
genetic sequences
receptor
sequences coding
hemopoietin receptor
components
Prior art date
Application number
AT96934193T
Other languages
English (en)
Inventor
Tracy Willson
Nicos Nicola
Douglas Hilton
Donald Metcalf
Jian Zhang
Original Assignee
Zenyth Operations Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27157889&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE445011(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from AUPN6135A external-priority patent/AUPN613595A0/en
Priority claimed from AUPN7276A external-priority patent/AUPN727695A0/en
Priority claimed from AUPO2208A external-priority patent/AUPO220896A0/en
Application filed by Zenyth Operations Pty Ltd filed Critical Zenyth Operations Pty Ltd
Application granted granted Critical
Publication of ATE445011T1 publication Critical patent/ATE445011T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compression, Expansion, Code Conversion, And Decoders (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT96934193T 1995-10-23 1996-10-23 Hemopoietin-rezeptor und dafür kodierende genetische sequenzen ATE445011T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPN6135A AUPN613595A0 (en) 1995-10-23 1995-10-23 A novel haemopoietin receptor and genetic sequences encoding same
AUPN7276A AUPN727695A0 (en) 1995-12-22 1995-12-22 A novel haempoietin receptor and genetic sequences encoding same - II
AUPO2208A AUPO220896A0 (en) 1996-09-09 1996-09-09 A novel haemopoietin receptor and genetic sequences encoding same - III
PCT/AU1996/000668 WO1997015663A1 (en) 1995-10-23 1996-10-23 A novel haemopoietin receptor and genetic sequences encoding same

Publications (1)

Publication Number Publication Date
ATE445011T1 true ATE445011T1 (de) 2009-10-15

Family

ID=27157889

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96934193T ATE445011T1 (de) 1995-10-23 1996-10-23 Hemopoietin-rezeptor und dafür kodierende genetische sequenzen

Country Status (8)

Country Link
EP (1) EP0907730B1 (de)
JP (2) JP4224135B2 (de)
AT (1) ATE445011T1 (de)
AU (1) AU718899C (de)
CA (1) CA2238080C (de)
DE (1) DE69638050D1 (de)
ES (1) ES2334408T3 (de)
WO (1) WO1997015663A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710023A (en) 1996-03-01 1998-01-20 Genetics Institute, Inc. IL-13 cytokine receptor chain
US7078494B1 (en) 1996-03-01 2006-07-18 Genetics Institute, Llc Antibodies to human IL-13bc and methods of their use in inhibiting IL-13 binding
AUPO224696A0 (en) * 1996-09-11 1996-10-03 Amrad Operations Pty. Limited A novel haemopoietin receptor and genetic sequences encoding same
GB9721961D0 (en) * 1997-10-16 1997-12-17 Glaxo Group Ltd Novel molecules
US6703488B1 (en) * 1998-01-15 2004-03-09 Center For Molecular Medicine And Immunology Antibody/receptor targeting moiety for enhanced delivery of armed ligand
US7553487B2 (en) 1998-12-14 2009-06-30 Genetics Institute, Llc Method and compositions for treating asthma
MXPA01006006A (es) 1998-12-14 2004-08-12 Genetics Inst Cadena receptora de citocina.
EP2325316B8 (de) 1999-06-02 2017-04-19 Chugai Seiyaku Kabushiki Kaisha Neues Hämopoietin Receptorprotein, NR10
AU7445900A (en) 1999-09-27 2001-04-30 Chugai Seiyaku Kabushiki Kaisha Novel hemopoietin receptor protein, nr12
AU2003212102B2 (en) * 2002-03-22 2010-01-14 Zenyth Operations Pty Ltd Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ralpha1)
CA2480059C (en) 2002-03-22 2015-11-24 Amrad Operations Pty. Ltd. Monoclonal antibody against interleukin-13 receptor alpha 1 (il-13r.alpha.1)
PL3718564T3 (pl) 2003-12-23 2024-03-18 Genentech, Inc. Nowe przeciwciała anty-IL 13 i ich zastosowania
AR049390A1 (es) 2004-06-09 2006-07-26 Wyeth Corp Anticuerpos contra la interleuquina-13 humana y usos de los mismos
US7501121B2 (en) 2004-06-17 2009-03-10 Wyeth IL-13 binding agents
EP1824886B1 (de) 2004-11-17 2010-12-22 Amgen Inc. Vollständige humane monoklonale antikörper gegen il-13
TWI306862B (en) 2005-01-03 2009-03-01 Hoffmann La Roche Antibodies against il-13 receptor alpha 1 and uses thereof
ES2429407T3 (es) 2006-06-08 2013-11-14 Chugai Seiyaku Kabushiki Kaisha Agente preventivo o remedio para enfermedades inflamatorias
PL2829551T3 (pl) 2006-10-19 2018-04-30 Csl Limited Antagonisty przeciwciała o wysokim powinowactwie wobec receptora alfa 1 interleukiny-13
AU2007319605B2 (en) 2006-10-19 2011-02-17 Csl Limited Anti-IL-13R alpha 1 antibodies and their uses thereof
CA2667067A1 (en) 2006-10-19 2008-04-24 Merck & Co., Inc. Antibody antagonists of interleukin-13 receptor .alpha.1
CA2708065C (en) 2007-12-05 2015-02-24 Chugai Seiyaku Kabushiki Kaisha Therapeutic agent for pruritus
CA2709127C (en) 2007-12-15 2013-11-12 F. Hoffmann-La Roche Ag Distinguishing assay
BR112015032960B1 (pt) 2013-07-04 2021-01-05 F. Hoffmann-La Roche Ag imunoensaio suprimido por interferência para detectar anticorpos anti-fármaco em amostras de soro
RU2016107435A (ru) 2013-09-13 2017-10-18 Дженентек, Инк. Композиции и способы обнаружения и количественного определения белка клеток-хозяев в клеточных линиях и рекомбинантные полипептидные продукты
CN120904322A (zh) 2013-09-13 2025-11-07 豪夫迈·罗氏有限公司 包含纯化的重组多肽的方法和组合物
WO2018106945A1 (en) 2016-12-07 2018-06-14 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
WO2018183932A1 (en) 2017-03-30 2018-10-04 Progenity Inc. Treatment of a disease of the gastrointestinal tract with a il-13 inhibitor
EP3883635A1 (de) 2018-11-19 2021-09-29 Progenity, Inc. Verfahren und vorrichtungen zur behandlung einer krankheit mit biotherapeutika
CN113677708A (zh) 2019-03-26 2021-11-19 亚狮康私人有限公司 采用抗il13r抗体或其结合片段的治疗
CN115666704B (zh) 2019-12-13 2025-09-26 比特比德科有限责任公司 用于将治疗剂递送至胃肠道的可摄取装置
WO2022186773A1 (en) 2021-03-01 2022-09-09 Aslan Pharmaceuticals Pte Ltd TREATMENT OF ATOPIC DERMATITIS EMPLOYING ANTI-IL-13Rα1 ANTIBODY OR BINDING FRAGMENT THEREOF IN AN ALLERGIC POPULATION
WO2022186772A1 (en) 2021-03-01 2022-09-09 Aslan Pharmaceuticals Pte Ltd TREATMENT OF ATOPIC DERMATITIS EMPLOYING ANTI-IL-13Rα1 ANTIBODY OR BINDING FRAGMENT THEREOF
WO2023048650A1 (en) 2021-09-27 2023-03-30 Aslan Pharmaceuticals Pte Ltd TREATMENT OF PRURITIS EMPLOYING ANTI-IL13Rα1 ANTIBODY OR BINDING FRAGMENT THEREOF
WO2023048651A1 (en) 2021-09-27 2023-03-30 Aslan Pharmaceuticals Pte Ltd Method for treatment of moderate to severe atoptic dematitis
WO2023075702A1 (en) 2021-10-29 2023-05-04 Aslan Pharmaceuticals Pte Ltd Anti-il-13r antibody formulation
EP4590335A1 (de) 2022-08-26 2025-07-30 ASLAN Pharmaceuticals Pte Ltd Hochkonzentrierte anti-il13r-antikörperformulierung
US20260078192A1 (en) 2022-09-06 2026-03-19 Aslan Pharmaceuticals Pte Ltd Treatment for sleep loss or sleep disturbance in patients with dermatitis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018653A (en) 1971-10-29 1977-04-19 U.S. Packaging Corporation Instrument for the detection of Neisseria gonorrhoeae without culture
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4424279A (en) 1982-08-12 1984-01-03 Quidel Rapid plunger immunoassay method and apparatus
EP0804576B1 (de) * 1994-09-05 2008-09-03 Amrad Operations Pty.,Ltd. Hemopoietin-rezeptor
WO1996011213A1 (en) * 1994-10-07 1996-04-18 Amgen Boulder Inc. Dimeric il-4 inhibitors
FR2742156A1 (fr) * 1995-12-06 1997-06-13 Sanofi Sa Polypeptide recepteur de l'il-13

Also Published As

Publication number Publication date
WO1997015663A1 (en) 1997-05-01
CA2238080C (en) 2012-03-13
EP0907730B1 (de) 2009-10-07
AU718899C (en) 2004-01-29
JPH11514873A (ja) 1999-12-21
DE69638050D1 (de) 2009-11-19
AU718899B2 (en) 2000-04-20
EP0907730A1 (de) 1999-04-14
EP0907730A4 (de) 2001-11-07
ES2334408T3 (es) 2010-03-09
AU7266896A (en) 1997-05-15
JP4224135B2 (ja) 2009-02-12
JP2008029340A (ja) 2008-02-14
CA2238080A1 (en) 1997-05-01

Similar Documents

Publication Publication Date Title
ATE445011T1 (de) Hemopoietin-rezeptor und dafür kodierende genetische sequenzen
NO995182D0 (no) Pattedyrcytokinlignende faktor 7
DE69918946D1 (de) Rezeptoren für il-18
CY1112101T1 (el) Νευροτροφικοι παραγοντες
DE69131249D1 (de) Durch menschliche lymphozyten produzierte proteine, die für diese proteine kodierende dns und pharmazeutische und biologische verwendungen
ATE309375T1 (de) Onkostatin- m rezeptor
FR2661187B1 (fr) Proteine associee a la pancreatite aiguue. moyens pour le diagnostic de la pancreatite aiguue.
SE9301755D0 (sv) A method of determining affinity and kinetic properties
NO990470D0 (no) Modifiserte TIE-2-reseptorligander
ATE476495T1 (de) Bazillus thuringiensis und dessen insektizide proteine
ATE407208T1 (de) Hemopoietin-rezeptor
WO1998011225A3 (en) A novel haemopoietin receptor and genetic sequences encoding same
DE60031576D1 (en) Diagnostisches assay für typ-2-heparin induzierte thrombocytopenie
TR199701469T1 (xx) �i�man (OB) proteinin etkilerini de�i�tiren bile�imlerin meydana ��kar�lmas� i�in y�ntem.
ATE175237T1 (de) Polypeptide beteiligt an der kobalamin- und/oder kobamid-biosynthese, für diese kodierende dns- sequencen, und ihre herstellung und vewendung.
TR200003467T2 (tr) Neisseria meningitidis antijenik polipeptidler, mütekabil polinükleotidler ve koruyucu antikorlar
MX9702863A (es) Proteinas asociadas con el hipocampo, secuencias de adn que codifican para las mismas y usos de las mismas.
DK0968288T3 (da) z219a, en human homolog til 2-19 protein
BR9808514A (pt) Proteìnas quiméricas do ligante flt3
ATE332974T1 (de) Il-1/tnf-alpha-activated kinase (itak), und verfahren zu ihrer herstellung und verwendung
ATE309371T1 (de) Protein mit dnase-aktivität
DE69535039D1 (de) Cytoplasmische tyrosin kinase
DE69421086D1 (de) Herstellung und anwendung von polypeptiden, die durch bindmolekuele markiert sind
NO940797L (no) Reseptorderivater som har bindingseter for human-rhinovirus
Williams Bridge

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties